Epstein Secrets

en and closed setting - with EFTA00135637 intelligence community heads like CIA Director Gina Haspel, FBI Director Christopher Wray, NSA Director Paul Nakasone and NGA Director Robert Sharp." Ratcliffe added that "a closed session with a thorough exchange of classified questions and answers between the pane

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting corn

e in both an open and closed setting — with intelligence community heads like CIA Director Gina Haspel, FBI Director Christopher Wray, NSA Director Paul Nakasone and NGA Director Robert Sharp." Ratcliffe added that "a closed session with a thorough exchange of classified questions and answers between the pane

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting corn

e in both an open and closed setting - with intelligence community heads like CIA Director Gina Haspel, FBI Director Christopher Wray, NSA Director Paul Nakasone and NGA Director Robert Sharp." Ratcliffe added that "a closed session with a thorough exchange of classified questions and answers between the pane

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting cor

e in both an open and closed setting - with intelligence community heads like CIA Director Gina Haspel, FBI Director Christopher Wray, NSA Director Paul Nakasone and NGA Director Robert Sharp." Ratcliffe added that "a closed session with a thorough exchange of classified questions and answers between the pane

ll guard against any pressure that comes from the FDA to lower its standards or to approve something that you know doesn't meet the standards." Dr. Macaya Douoguih, Janssen Vaccines Clinical Development & Medical Affairs: "We are working around the clock to accelerate our development, but we're not cutting cor